Press release
Acadia Healthcare Company Inc (NASDAQ: ACHC) Investor Alert: Update in Lawsuit
An update was announced in the lawsuit that was filed for certain investors in Acadia Healthcare Company Inc (NASDAQ: ACHC).
Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On October 02, 2023, a lawsuit was filed in the U.S. District Court for the Middle District of Tennessee against Acadia Healthcare Company Inc over alleged securities laws violations. The plaintiff alleged that between February 23, 2017 and October 24, 2017, the defendants made materially false and misleading statements regarding Acadia's business and operations, including by falsely stating that the quality of Acadia's U.K. operations gave it a "competitive strength" that would drive future growth and profitability, and by issuing false and misleading guidance regarding the Company's actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization ("EBITDA") and earnings per share ("EPS"), and that as a result of defendants' false statements, Acadia stock traded at artificially inflated prices of more than $52 per share February 23, 2017 and October 24, 2017, and that while Acadia stock was trading at these allegedly artificially inflated prices, the Company's CEO and President sold 706,000 shares of their Acadia stock for proceeds of more than $35 million.
On April 1, 2019 a consolidated complaint was filed and on May 31, 2019, the defendants filed their motion to dismiss the consolidated complaint.
On January 20, 2021, the court denied the defendants' motion to dismiss.
On February 1, 2022, a motion for class certification was filed, which the court granted on September 30, 2022.
Those who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acadia Healthcare Company Inc (NASDAQ: ACHC) Investor Alert: Update in Lawsuit here
News-ID: 3244370 • Views: …
More Releases from Shareholders Foundation
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for Acadia
Navigating the Future: Japan Pharmaceutical Manufacturing Market | Abbott Labora …
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Japan Pharmaceutical Manufacturing Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition.
Access the Comprehensive PDF Market Research Analysis Report Here: https://www.astuteanalytica.com/request-sample/japan-pharmaceutical-manufacturing-market
Japan pharmaceutical manufacturing market was valued at US$ 31.74 billion in 2022…
Behavioral Health Market May See Big Move | Acadia Healthcare, Ascension Seton, …
Behavioral Health Market is latest research study released by AMA Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Behavioral Health Market. Some of the key players profiled in the study are Acadia Healthcare (United States), CareTech Holdings (United Kingdom), The MENTOR Network…
Glaucoma Pharmaceuticals Market to Witness Huge Growth by 2027 | Allergan, Merck …
The Latest survey report on Glaucoma Pharmaceuticals Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Glaucoma Pharmaceuticals organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Acadia Pharmaceuticals Inc., Allergan Inc., Inotek Pharmaceuticals Corporation, Merck & Co. Inc., Santen…
Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc..
Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA…
Lawsuit filed for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based…
Investigation announced for Investors in shares of ACADIA Pharmaceuticals Inc. ( …
ACADIA Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by ACADIA Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false…
